Biological evaluation and spectral characterization of a novel tetracenomycin X congener.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 07 08 2021
revised: 21 09 2021
accepted: 23 09 2021
pubmed: 1 10 2021
medline: 5 2 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

The aromatic polyketide tetracenomycin X (TcmX) was recently found to be a potent inhibitor of protein synthesis; its binding site is located in a unique locus within the tunnel of the large ribosomal subunit. The distinct mode of action makes this relatively narrow class of aromatic polyketides promising for drug development in the quest to prevent the spread of drug-resistant pathogens. Here we report the isolation and structure elucidation of a novel natural tetracenomycin X congener - 6-hydroxytetraceonomycin X (6-OH-TcmX). In contrast to TcmX, 6-OH-TcmX exhibited lower antimicrobial and cytotoxic activity, but comparable in vitro protein synthesis inhibition ability. A survey on spectral properties of tetracenomycins revealed profound differences in both UV-absorption and fluorescence spectra between TcmX and 6-OH-TcmX, suggesting a significant influence of 6-hydroxylation on the tetracenomycin X chromophore. Nonetheless, characteristic spectral properties of tetracenomycins make them suitable candidates for semi-synthetic drug development (e.g., for targeted delivery, chemical biology, or cell imaging).

Identifiants

pubmed: 34592388
pii: S0300-9084(21)00226-1
doi: 10.1016/j.biochi.2021.09.014
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Naphthacenes 0
tetracenomycin X 121245-07-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-71

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Vera A Alferova (VA)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya 11, Moscow, 119021, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, Moscow, 117997, Russia.

Tinashe P Maviza (TP)

Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, 143028, Russia.

Mikhail V Biryukov (MV)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya 11, Moscow, 119021, Russia; Department of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia; Genetics and Life Sciences Research Center, Sirius University of Science and Technology, Sochi, 354340, Russia.

Yuliya V Zakalyukina (YV)

Genetics and Life Sciences Research Center, Sirius University of Science and Technology, Sochi, 354340, Russia; Department of Soil Science, Lomonosov Moscow State University, Moscow, 119234, Russia.

Dmitrii A Lukianov (DA)

Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, 143028, Russia.

Dmitry A Skvortsov (DA)

Department of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia.

Lilia A Vasilyeva (LA)

Department of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia.

Vadim N Tashlitsky (VN)

Department of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia.

Vladimir I Polshakov (VI)

Center for Magnetic Tomography and Spectroscopy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, 119991, Russia.

Petr V Sergiev (PV)

Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, 143028, Russia; Department of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia.

Vladimir A Korshun (VA)

Gause Institute of New Antibiotics, Bolshaya Pirogovskaya 11, Moscow, 119021, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, Moscow, 117997, Russia.

Ilya A Osterman (IA)

Center of Life Sciences, Skolkovo Institute of Science and Technology, Skolkovo, 143028, Russia; Genetics and Life Sciences Research Center, Sirius University of Science and Technology, Sochi, 354340, Russia; Department of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia. Electronic address: i.osterman@skoltech.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH